Karen completed her Bachelor’s of Science from the University of Toronto in 2012. She then went on to complete her Master of Science in diabetic drug discovery under Dr Xiao-Yan Wen, (http://stmichaelshospitalresearch.ca/researchers/xiao-yan-wen/), at St Michael’s Hospital, a teaching hospital affiliated with the University of Toronto. Karen joined the Escobar-Hoyos/Shroyer lab in 2016 via Stony Brook Medicine’s Scholarly Concentrations Program. She is currently a Pathology resident at Stony Brook Medicine.


Karen is interested in investigating diagnostic and/or prognostic biomarkers in uterine cancer. Her most recent presentation include her poster on keratin 17 as a negative prognostic biomarker in endometrial carcinoma, presented at the American Society for Investigative Pathology Annual Meeting in 2018.


Twitter: @KarenBaiBai

LinkedIn: https://www.linkedin.com/in/karen-bai-919a558/

SciENcv: https://www.ncbi.nlm.nih.gov/myncbi/1097vKDnp6KseL/cv/294799/